Synthesis and Evaluation of [N-methyl-11C]N-Desmethyl-loperamide as a New and Improved PET Radiotracer for Imaging P-gp Function
[11C]Loperamide has been proposed for imaging P-glycoprotein (P-gp) function with positron emission tomography (PET), but its metabolism to [N-methyl-11C]N-desmethyl-loperamide ([11C]dLop; [11C]3) precludes quantification. We considered that [11C]3 might itself be a superior radiotracer for imaging...
Saved in:
Published in | Journal of medicinal chemistry Vol. 51; no. 19; pp. 6034 - 6043 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
WASHINGTON
American Chemical Society
09.10.2008
Amer Chemical Soc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | [11C]Loperamide has been proposed for imaging P-glycoprotein (P-gp) function with positron emission tomography (PET), but its metabolism to [N-methyl-11C]N-desmethyl-loperamide ([11C]dLop; [11C]3) precludes quantification. We considered that [11C]3 might itself be a superior radiotracer for imaging brain P-gp function and therefore aimed to prepare [11C]3 and characterize its efficacy. An amide precursor (2) was synthesized and methylated with [11C]iodomethane to give [11C]3. After administration of [11C]3 to wild-type mice, brain radioactivity uptake was very low. In P-gp (mdr-1a(−/−)) knockout mice, brain uptake of radioactivity at 30 min increased about 3.5-fold by PET measures, and over 7-fold by ex vivo measures. In knockout mice, brain radioactivity was predominantly (90%) unchanged radiotracer. In monkey PET experiments, brain radioactivity uptake was also very low but after P-gp blockade increased more than 7-fold. [11C]3 is an effective new radiotracer for imaging brain P-gp function and, in favor of future successful quantification, appears free of extensive brain-penetrant radiometabolites. |
---|---|
AbstractList | [
11
C]Loperamide has been proposed for imaging P-glycoprotein (P-gp) function with positron emission tomography (PET), but its metabolism to [
N-methyl
-
11
C]
N
-
desmethyl
-loperamide ([
11
C]dLop; [
11
C]
3
) precludes quantification. We considered that [
11
C]
3
might itself be a superior radiotracer for imaging brain P-gp function and therefore aimed to prepare [
11
C]
3
and characterize its efficacy. An amide precursor (
2
) was synthesized and methylated with [
11
C]iodomethane to give [
11
C]
3
. After administration of [
11
C]
3
to wild type mice, brain radioactivity uptake was very low. In P-gp (
mdr-1a
(−/−)) knockout mice, brain uptake of radioactivity at 30 min increased about 3.5 fold by PET measures, and over seven-fold by ex vivo measures. In knockout mice, brain radioactivity was predominantly (90%) unchanged radiotracer. In monkey PET experiments, brain radioactivity uptake was also very low, but after P-gp blockade increased more than seven-fold. [
11
C]
3
is an effective new radiotracer for imaging brain P-gp function and, in favor of future successful quantification, appears free of extensive brain-penetrant radiometabolites. [(11)C]Loperamide has been proposed for imaging P-glycoprotein (P-gp) function with positron emission tomography (PET), but its metabolism to [N-methyl-(11)C] N-desmethyl-loperamide ([(11)C]dLop; [(11)C]3) precludes quantification. We considered that [(11)C]3 might itself be a superior radiotracer for imaging brain P-gp function and therefore aimed to prepare [(11)C]3 and characterize its efficacy. An amide precursor (2) was synthesized and methylated with [(11)C]iodomethane to give [(11)C]3. After administration of [(11)C]3 to wild-type mice, brain radioactivity uptake was very low. In P-gp (mdr-1a(-/-)) knockout mice, brain uptake of radioactivity at 30 min increased about 3.5-fold by PET measures, and over 7-fold by ex vivo measures. In knockout mice, brain radioactivity was predominantly (90%) unchanged radiotracer. In monkey PET experiments, brain radioactivity uptake was also very low but after P-gp blockade increased more than 7-fold. [(11)C]3 is an effective new radiotracer for imaging brain P-gp function and, in favor of future successful quantification, appears free of extensive brain-penetrant radiometabolites. [C-11]Loperamide has been proposed for imaging P-glycoprotein (P-gp) function with positron emission tomography (PET), but its metabolism to [N-methyl-C-11]N-desmethyl-loperamide ([C-11]dLop; [C-11]3) precludes quantification. We considered that [C-11]3 might itself be a superior radiotracer for imaging brain P-gp function and therefore aimed to prepare [C-11]3 and characterize its efficacy. An amide precursor (2) was synthesized and methylated with [C-11]iodomethane to give [C-11]3. After administration of [C-11]3 to wild-type mice, brain radioactivity uptake was very low. In P-gp (mdr-la(-/-)) knockout mice, brain uptake of radioactivity at 30 min increased about 3.5-fold by PET measures, and over 7-fold by ex vivo measures. In knockout mice, brain radioactivity was predominantly (90%) unchanged radiotracer. In monkey PET experiments, brain radioactivity uptake was also very low but after P-gp blockade increased more than 7-fold. [C-11]3 is an effective new radiotracer for imaging brain P-gp function and, in favor of future successful quantification, appears free of extensive brain-penetrant radiometabolites. [11C]Loperamide has been proposed for imaging P-glycoprotein (P-gp) function with positron emission tomography (PET), but its metabolism to [N-methyl-11C]N-desmethyl-loperamide ([11C]dLop; [11C]3) precludes quantification. We considered that [11C]3 might itself be a superior radiotracer for imaging brain P-gp function and therefore aimed to prepare [11C]3 and characterize its efficacy. An amide precursor (2) was synthesized and methylated with [11C]iodomethane to give [11C]3. After administration of [11C]3 to wild-type mice, brain radioactivity uptake was very low. In P-gp (mdr-1a(−/−)) knockout mice, brain uptake of radioactivity at 30 min increased about 3.5-fold by PET measures, and over 7-fold by ex vivo measures. In knockout mice, brain radioactivity was predominantly (90%) unchanged radiotracer. In monkey PET experiments, brain radioactivity uptake was also very low but after P-gp blockade increased more than 7-fold. [11C]3 is an effective new radiotracer for imaging brain P-gp function and, in favor of future successful quantification, appears free of extensive brain-penetrant radiometabolites. |
Author | Seneca, Nicholas Tuan, Ed Taku, Andrew Liow, Jeih-San Lazarova, Neva Pike, Victor W Hong, Jinsoo Gladding, Robert L Zoghbi, Sami S Innis, Robert B |
Author_xml | – sequence: 1 givenname: Neva surname: Lazarova fullname: Lazarova, Neva – sequence: 2 givenname: Sami S surname: Zoghbi fullname: Zoghbi, Sami S – sequence: 3 givenname: Jinsoo surname: Hong fullname: Hong, Jinsoo – sequence: 4 givenname: Nicholas surname: Seneca fullname: Seneca, Nicholas – sequence: 5 givenname: Ed surname: Tuan fullname: Tuan, Ed – sequence: 6 givenname: Robert L surname: Gladding fullname: Gladding, Robert L – sequence: 7 givenname: Jeih-San surname: Liow fullname: Liow, Jeih-San – sequence: 8 givenname: Andrew surname: Taku fullname: Taku, Andrew – sequence: 9 givenname: Robert B surname: Innis fullname: Innis, Robert B – sequence: 10 givenname: Victor W surname: Pike fullname: Pike, Victor W email: pikev@mail.nih.gov |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20746752$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/18783208$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkk1vEzEQhi1URD_gwB9AvnBAaKk_4l3ngoRCCpWiENEAEghZs15v4nTXjuxNSm78dJwmpIB64OSx5nnfGc3MKTpy3hmEnlLyihJGzxetJERQ0j5AJ1QwkvUk6R2hE0IYy1jO-DE6jXFBCOGU8UfomMpCckbkCfp5tXHd3EQbMbgKD9fQrKCz3mFf42_jrDXdfNNklA6-j7O3Ju7_jV-aAK2tDIakxGNzc6u_bJfBr02FJ8Mp_giV9V0AbQKufUhJmFk3w5NstsQXK6e3dR6jhzU00TzZv2fo08VwOnifjT68uxy8GWUgSN5lNSmMZjWUmuqCVbSkQtYGKsEFL4FxVhGZS9OXsuqD0RUVXFLQOQVOdJ-W_Ay93vkuV2VrKm1c6qxRy2BbCBvlwaq_M87O1cyvFct7ORMiGTz70-Cg_D3LBDzfAxA1NHUAp208cIwUvbwQLHFyx92Y0tdRW-O0OWBpSUz0i5yIbUQHtrtdx8CvXJekL_9fmugXO1oHH2Mw9V3PRG0PRx0OJ7Hn_7B6XzkNwzb3KrKdwsbO_DhYQ7hWecELoaaTKzViXya9r8VnRe_GAzqqhV8Fl9Z9j-8vbo7fEQ |
CODEN | JMCMAR |
CitedBy_id | crossref_primary_10_1016_j_jconrel_2018_11_009 crossref_primary_10_1177_0271678X16654493 crossref_primary_10_1016_j_tetlet_2012_12_121 crossref_primary_10_1038_clpt_2009_138 crossref_primary_10_1016_j_jconrel_2021_12_031 crossref_primary_10_3390_pharmaceutics14122650 crossref_primary_10_2217_pgs_10_197 crossref_primary_10_1016_j_bmcl_2013_08_024 crossref_primary_10_1016_j_nucmedbio_2009_03_004 crossref_primary_10_1021_cn3001729 crossref_primary_10_2967_jnumed_112_111732 crossref_primary_10_2967_jnumed_109_070151 crossref_primary_10_2967_jnumed_113_130161 crossref_primary_10_1177_0271678X211045444 crossref_primary_10_1021_mp400396k crossref_primary_10_1016_j_pharmthera_2018_04_006 crossref_primary_10_1021_acs_molpharmaceut_3c01036 crossref_primary_10_1073_pnas_1014641108 crossref_primary_10_1016_j_drup_2012_02_002 crossref_primary_10_1124_dmd_108_024745 crossref_primary_10_1016_j_nucmedbio_2009_10_006 crossref_primary_10_1016_j_nucmedbio_2015_09_001 crossref_primary_10_1007_s12149_013_0725_5 crossref_primary_10_1007_s11307_016_0965_6 crossref_primary_10_1186_2191_219X_3_3 crossref_primary_10_1177_0271678X231202336 crossref_primary_10_1002_jlcr_2993 crossref_primary_10_2967_jnumed_115_164350 crossref_primary_10_2967_jnumed_124_269322 crossref_primary_10_1002_jps_22822 crossref_primary_10_1016_j_nucmedbio_2012_06_013 crossref_primary_10_1186_2191_219X_1_12 crossref_primary_10_1002_cmdc_201300362 crossref_primary_10_1016_j_ejps_2016_06_005 crossref_primary_10_1038_s41568_018_0005_8 crossref_primary_10_1016_j_bmc_2011_02_039 crossref_primary_10_1124_dmd_109_031161 crossref_primary_10_1002_ejoc_200901321 crossref_primary_10_1016_j_bmcl_2024_129818 crossref_primary_10_1016_j_tips_2009_05_005 crossref_primary_10_1016_j_bmc_2010_06_097 crossref_primary_10_1038_jcbfm_2009_160 crossref_primary_10_2967_jnumed_108_058453 crossref_primary_10_2967_jnumed_114_146894 crossref_primary_10_1002_jlcr_3957 crossref_primary_10_1016_j_bmc_2010_06_057 crossref_primary_10_1021_acschemneuro_1c00382 crossref_primary_10_1016_j_ejps_2023_106404 crossref_primary_10_2174_1568026623666221025111528 crossref_primary_10_1016_j_eplepsyres_2010_12_013 crossref_primary_10_1021_acs_molpharmaceut_5b00168 crossref_primary_10_1021_acsptsci_3c00200 crossref_primary_10_1039_c002361b crossref_primary_10_1016_j_apsb_2021_08_013 crossref_primary_10_1039_c0dt01275k crossref_primary_10_4236_aad_2013_21003 crossref_primary_10_1186_1471_2342_11_1 crossref_primary_10_1021_mp200563a crossref_primary_10_1016_j_ejmech_2016_04_058 crossref_primary_10_1016_j_nucmedbio_2009_12_010 crossref_primary_10_2967_jnumed_116_181354 crossref_primary_10_1016_j_neuroimage_2011_12_037 crossref_primary_10_1016_j_nucmedbio_2013_05_008 crossref_primary_10_3390_molecules171214288 crossref_primary_10_2967_jnumed_108_056226 |
Cites_doi | 10.1016/0014-2999(77)90334-X 10.1007/s11307-005-0951-x 10.1021/jm00265a009 10.2967/jnumed.107.047308 10.1177/38.9.1974900 10.1016/S0969-8043(96)00177-7 10.1109/TNS.2003.817282 10.2967/jnumed.106.038778 10.1038/nrc706 10.1002/syn.20348 10.1172/JCI1269 10.1177/026988119300700202 10.1021/jm0707370 10.1016/j.mibio.2003.09.014 10.1002/bms.1200060606 10.1097/00008571-200210000-00005 10.1162/15353500200504166 10.1172/JCI118699 10.1016/0092-8674(94)90212-7 10.1016/0960-894X(95)00426-T 10.1002/ana.20369 10.1016/S0022-3565(24)34974-2 10.1016/0165-0270(88)90184-7 10.1046/j.1471-4159.2001.00113.x 10.1007/BF01295711 10.1067/mcp.2000.109156 10.1016/S0090-9556(24)02977-5 10.1002/ijc.10792 10.1093/jnen/63.10.1038 10.1172/JCI25247 10.1016/S0169-409X(97)00504-8 10.2174/1381612043384736 |
ContentType | Journal Article |
Copyright | Copyright © 2008 American Chemical Society 2009 INIST-CNRS |
Copyright_xml | – notice: Copyright © 2008 American Chemical Society – notice: 2009 INIST-CNRS |
DBID | BSCLL AAYXX CITATION 17B 1KM BLEPL DTL EGQ GAYFB IQODW CGR CUY CVF ECM EIF NPM 5PM |
DOI | 10.1021/jm800510m |
DatabaseName | Istex CrossRef Web of Knowledge Index Chemicus Web of Science Core Collection Science Citation Index Expanded Web of Science Primary (SCIE, SSCI & AHCI) Web of Science - Science Citation Index Expanded - 2008 Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef Web of Science MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE Web of Science |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 1KM name: Index Chemicus url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC sourceTypes: Enrichment Source Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | Synthesis and Evaluation of [11C]N-Desmethyl-loperamide |
EISSN | 1520-4804 |
EndPage | 6043 |
ExternalDocumentID | PMC2646255 18783208 20746752 000259760500021 10_1021_jm800510m ark_67375_TPS_L2WP4Z7V_1 c789292902 |
Genre | Journal Article Research Support, N.I.H., Intramural Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NATIONAL INSTITUTE OF MENTAL HEALTH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH) grantid: Z01MH002795 – fundername: National Institute of Mental Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH) grantid: Z01-MH-002795-04 – fundername: NIMH NIH HHS grantid: N01 MH032004 – fundername: Intramural NIH HHS grantid: Z01 MH002795 – fundername: NIMH NIH HHS grantid: Z01-MH-002795-04 – fundername: Intramural NIH HHS grantid: Z01 MH002793 |
GroupedDBID | - .K2 4.4 53G 55A 5GY 5RE 5VS 7~N AABXI ABFLS ABMVS ABOCM ABPTK ABUCX ACGFS ACJ ACS AEESW AENEX AFEFF AFFNX ALMA_UNASSIGNED_HOLDINGS ANTXH AQSVZ BAANH CS3 DU5 EBS ED ED~ EJD F5P GNL IH9 IHE JG JG~ K2 L7B LG6 P2P ROL TN5 UI2 VF5 VG9 W1F WH7 X XFK YZZ ZY4 --- -~X AAHBH AAYOK ABJNI ABQRX ABTAH ACGFO ADHLV AGXLV AHGAQ BSCLL CUPRZ GGK IH2 XSW YQT AAYXX ABBLG ABLBI ACRPL ADNMO AGQPQ ANPPW CITATION 17B 1KM BLEPL DTL GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED GROUPED_WOS_WEB_OF_SCIENCE .55 .GJ .HR 1KJ 1WB 3EH 3O- 6P2 6TJ 9M8 ABHMW ADXHL AEYZD IQODW MVM NHB OHT RNS UBC X7M ZE2 ZGI CGR CUY CVF ECM EIF NPM 5PM |
ID | FETCH-LOGICAL-a506t-f07ec2fabc1c72d1b158fead5353ba232d0868e988d9aecd15381ac61a30c91b3 |
IEDL.DBID | ACS |
ISICitedReferencesCount | 79 |
ISICitedReferencesURI | https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000259760500021 |
ISSN | 0022-2623 |
IngestDate | Thu Aug 21 14:06:15 EDT 2025 Mon Jul 21 05:47:00 EDT 2025 Mon Jul 21 09:12:20 EDT 2025 Wed Aug 06 04:52:48 EDT 2025 Fri Aug 29 16:03:25 EDT 2025 Thu Apr 24 23:14:49 EDT 2025 Tue Jul 01 02:13:16 EDT 2025 Wed Oct 30 09:42:09 EDT 2024 Thu Aug 27 13:42:06 EDT 2020 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 19 |
Keywords | GLYCOPROTEIN FUNCTION TRANSPORTER RADIOMETABOLITE IN-VIVO LOPERAMIDE OPIOID RECEPTORS MULTIDRUG-RESISTANCE BLOOD-BRAIN-BARRIER EXPRESSION MODULATION Transmembrane protein Loperamide Intravenous administration Radiolabelling Rodentia P Glycoprotein Monkey Central nervous system Antidiarrheal agent Carbon Isotopes Vertebrata Mammalia Mouse Scintigraphic agent Animal Piperidine derivatives Primates Carbon 11 Carboxamide Chemical synthesis Positron emission tomography Carrier protein |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
LogoURL | https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg |
MergedId | FETCHMERGED-LOGICAL-a506t-f07ec2fabc1c72d1b158fead5353ba232d0868e988d9aecd15381ac61a30c91b3 |
Notes | HPLC chromatograms verifying the purities of compounds 1−3 and PET time−activity data for brain regions in P-gp inhibited monkey given naloxone after radiotracer [11C]3. This material is available free of charge via the Internet at http://pubs.acs.org. ark:/67375/TPS-L2WP4Z7V-1 istex:A4E18CC67AA463F22B03CB1B8894525F822520AD NIH RePORTER |
OpenAccessLink | http://doi.org/10.1021/jm800510m |
PMID | 18783208 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2646255 webofscience_primary_000259760500021CitationCount crossref_primary_10_1021_jm800510m pubmed_primary_18783208 pascalfrancis_primary_20746752 crossref_citationtrail_10_1021_jm800510m webofscience_primary_000259760500021 istex_primary_ark_67375_TPS_L2WP4Z7V_1 acs_journals_10_1021_jm800510m |
ProviderPackageCode | JG~ 55A AABXI GNL VF5 7~N ACJ VG9 W1F ANTXH ACS AEESW AFEFF .K2 ABMVS ABUCX IH9 BAANH AQSVZ ED~ UI2 CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2008-10-09 |
PublicationDateYYYYMMDD | 2008-10-09 |
PublicationDate_xml | – month: 10 year: 2008 text: 2008-10-09 day: 09 |
PublicationDecade | 2000 |
PublicationPlace | WASHINGTON |
PublicationPlace_xml | – name: WASHINGTON – name: Columbus, OH – name: United States |
PublicationTitle | Journal of medicinal chemistry |
PublicationTitleAbbrev | J MED CHEM |
PublicationTitleAlternate | J. Med. Chem |
PublicationYear | 2008 |
Publisher | American Chemical Society Amer Chemical Soc |
Publisher_xml | – name: American Chemical Society – name: Amer Chemical Soc |
References | Kim R. B. (ref4/cit4) 1998; 101 Kortekaas R. (ref10/cit10) 2005; 57 Jones A. K. P. (ref33/cit33) 1988; 23 Passchier J. (ref19/cit19) 2003; 5 Elsinga P. H. (ref13/cit13) 2004; 10 Talbot P. S. (ref35/cit35) 2005; 46 Liow J. (ref47/cit47) 2003; 44 Elsinga P. H. (ref12/cit12) 2005; 7 Kurdziel K. (ref17/cit17) 2003; 44 Waterhouse R. N. (ref29/cit29) 2003; 5 Yoshida K. (ref26/cit26) 1979; 6 Pike V. W. (ref28/cit28) 1993; 7 Shepard R. L. (ref31/cit31) 2003; 103 ref42/cit42 Shiue C. Y. (ref34/cit34) 1991; 18 Elsinga P. H. (ref15/cit15) 1996; 37 Zoghbi S. S. (ref43/cit43) 1997; 40 Paxinos G. (ref48/cit48) 2001 ref38/cit38 Gottesman M. (ref5/cit5) 2002; 2 Vogelgesang S. (ref8/cit8) 2002; 12 ref50/cit50 Tsuji A. (ref1/cit1) 1997; 25 Langford D. (ref9/cit9) 2004; 63 Takano A. (ref16/cit16) 2006; 47 DelVecchio S. (ref21/cit21) 1997; 24 Larsen P. (ref41/cit41) 1997; 48 Madar I. (ref36/cit36) 2007; 48 Awouters F. (ref22/cit22) 1993; 38 Pfister J. R. (ref37/cit37) 1995; 5 Lam F. C. (ref6/cit6) 2001; 76 Cirrito J. R. (ref7/cit7) 2005; 115 Kalgutkar A. S. (ref25/cit25) 2004; 32 Schnkel A. H. (ref39/cit39) 1994; 77 Stokbroekx R. A. (ref27/cit27) 1973; 16 Dantzig A. H. (ref32/cit32) 1999; 290 Clark J. D. (ref40/cit40) 1996 Wilson A. A. (ref20/cit20) 2005; 48 Johnson C. A. (ref46/cit46) 2002; 4 Zoghbi S. S. (ref24/cit24) 2008; 49 Stahl K. D. (ref30/cit30) 1977; 46 Zoghbi S. S. (ref49/cit49) 2006; 47 Liow J. S. (ref11/cit11) 2007; 96 Levchenko A. (ref14/cit14) 2000; 41 Seidel J. (ref45/cit45) 2003; 50 Briard E. (ref44/cit44) 2008; 51 Bigott H. (ref18/cit18) 2005; 4 Cordon-Cardo C. (ref2/cit2) 1990; 9 Schinkel A. (ref3/cit3) 1996; 97 Sadeque A. J. M. (ref23/cit23) 2000; 68 DelVecchio, S (WOS:A1997WL94900008) 1997; 24 STAHL, KD (WOS:A1977ED77900002) 1977; 46 Bigott, Heather M (MEDLINE:15967124); 4 Liow, JS (WOS:000242789700005) 2007; 61 Wilson, AA (WOS:000267210100139) 2005; 48 Tsuji, A (WOS:A1997XJ12900008) 1997; 25 Zoghbi, SS (WOS:000249695800023) 2006; 47 Liow, J (WOS:000182729600530) 2003; 44 PAXINOS G (WOS:000259760500021.28) 2001 Lam, FC (WOS:000167049800019) 2001; 76 Cirrito, JR (WOS:000233022100038) 2005; 115 Kortekaas, R (WOS:000226633800004) 2005; 57 Takano, A (WOS:000240460600010) 2006; 47 Langford, D (WOS:000224500300004) 2004; 63 Pike, Victor W. (BCI:BCI199345056897) 1993; 7 Schinkel, AH (WOS:A1996UQ23800016) 1996; 97 CLARK JD (WOS:000259760500021.6) 1996 Vogelgesang, S (WOS:000178635900005) 2002; 12 Briard, E (WOS:000252127200003) 2008; 51 Kim, RB (WOS:000071668000002) 1998; 101 Madar, I (WOS:000244115600025) 2007; 48 Dantzig, AH (WOS:000081583900051) 1999; 290 Sadeque, AJM (WOS:000089560000002) 2000; 68 STOKBROEKX, RA (WOS:A1973Q001400009) 1973; 16 SCHINKEL, AH (WOS:A1994NM83200005) 1994; 77 Seidel, J (WOS:000185922200005) 2003; 50 ZOGHBI SS (WOS:000259760500021.49) 1997 JOHNSON CA (WOS:000259760500021.14) 2002; 4 Kurdziel, KA (WOS:000184650900024) 2003; 44 Zoghbi, SS (WOS:000254813600026) 2008; 49 JONES, AKP (WOS:A1988M531900006) 1988; 23 Talbot, PS (WOS:000227481700023) 2005; 46 Kalgutkar, AS (WOS:000223375500010) 2004; 32 CARSON RE (WOS:000259760500021.4) 2003 WEBER D (WOS:000259760500021.44) 1989 Levchenko, A (WOS:000085725300023) 2000; 41 YOSHIDA, K (WOS:A1979HL69800005) 1979; 6 Larsen, P (WOS:A1997WF43900001) 1997; 48 CORDONCARDO, C (WOS:A1990DV50300004) 1990; 38 Shepard, RL (WOS:000179696100019) 2003; 103 Elsinga, PH (WOS:000244957700007) 2005; 7 PFISTER, JR (WOS:A1995TC82800005) 1995; 5 Gottesman, MM (WOS:000180397700014) 2002; 2 Elsinga, PH (WOS:A1996VF79700046) 1996; 37 Elsinga, PH (WOS:000221066400004) 2004; 10 PASSCHIER J (WOS:000259760500021.27) 2003; 5 AWOUTERS, F (WOS:A1993LG50500001) 1993; 38 SHIUE, CY (WOS:A1991FF20500003) 1991; 18 Waterhouse, Rikki N (MEDLINE:14667492); 5 |
References_xml | – volume: 46 start-page: 199 year: 1977 ident: ref30/cit30 publication-title: Eur. J. Pharmacol. doi: 10.1016/0014-2999(77)90334-X – volume: 7 start-page: 37 year: 2005 ident: ref12/cit12 publication-title: Mol. Imaging Biol. doi: 10.1007/s11307-005-0951-x – volume: 46 start-page: 484 year: 2005 ident: ref35/cit35 publication-title: J. Nucl. Med. – volume: 16 start-page: 782 year: 1973 ident: ref27/cit27 publication-title: J. Med. Chem. doi: 10.1021/jm00265a009 – volume: 49 start-page: 649 year: 2008 ident: ref24/cit24 publication-title: J. Nucl. Med. doi: 10.2967/jnumed.107.047308 – ident: ref50/cit50 – volume: 9 start-page: 1277 year: 1990 ident: ref2/cit2 publication-title: J. Histochem. Cytochem. doi: 10.1177/38.9.1974900 – volume: 44 start-page: 162P year: 2003 ident: ref47/cit47 publication-title: J. Nucl. Med. – volume: 40 start-page: 136 year: 1997 ident: ref43/cit43 publication-title: J. Labelled Compd. Radiopharm. – volume-title: Guide for the Care and Use of Laboratory Animals year: 1996 ident: ref40/cit40 – volume: 48 start-page: 153 year: 1997 ident: ref41/cit41 publication-title: Appl. Radiat. Isot. doi: 10.1016/S0969-8043(96)00177-7 – volume: 50 start-page: 1347 year: 2003 ident: ref45/cit45 publication-title: IEEE Trans. Nucl. Sci. doi: 10.1109/TNS.2003.817282 – volume: 48 start-page: 207 year: 2007 ident: ref36/cit36 publication-title: J. Nucl. Med. doi: 10.2967/jnumed.106.038778 – volume: 37 start-page: 1571 year: 1996 ident: ref15/cit15 publication-title: J. Nucl. Med. – volume-title: The Rat Brain in Stereotaxic Coordinates year: 2001 ident: ref48/cit48 – volume: 2 start-page: 48 year: 2002 ident: ref5/cit5 publication-title: Nat. Rev. Cancer. doi: 10.1038/nrc706 – volume: 96 start-page: 96 year: 2007 ident: ref11/cit11 publication-title: Synapse doi: 10.1002/syn.20348 – volume: 18 start-page: 281 year: 1991 ident: ref34/cit34 publication-title: Nucl. Med. Biol. – volume: 48 start-page: S142 year: 2005 ident: ref20/cit20 publication-title: J. Labelled Compd. Radiopharm. – volume: 24 start-page: 0 year: 1997 ident: ref21/cit21 publication-title: Eur. J. Nucl. Med – volume: 101 start-page: 289 year: 1998 ident: ref4/cit4 publication-title: J. Clin. Invest. doi: 10.1172/JCI1269 – volume: 7 start-page: 139 year: 1993 ident: ref28/cit28 publication-title: J. Psychopharmacol. doi: 10.1177/026988119300700202 – volume: 51 start-page: 17 year: 2008 ident: ref44/cit44 publication-title: J. Med. Chem. doi: 10.1021/jm0707370 – volume: 5 start-page: 376 year: 2003 ident: ref29/cit29 publication-title: Mol. Imaging Biol. doi: 10.1016/j.mibio.2003.09.014 – ident: ref42/cit42 – volume: 5 start-page: 121 year: 2003 ident: ref19/cit19 publication-title: Mol. Imaging Biol. – volume: 6 start-page: 253 year: 1979 ident: ref26/cit26 publication-title: Biomed. Mass Spectrom. doi: 10.1002/bms.1200060606 – ident: ref38/cit38 – volume: 12 start-page: 535 year: 2002 ident: ref8/cit8 publication-title: Pharmacogenetics doi: 10.1097/00008571-200210000-00005 – volume: 4 start-page: 30 year: 2005 ident: ref18/cit18 publication-title: Mol. Imaging doi: 10.1162/15353500200504166 – volume: 97 start-page: 2517 year: 1996 ident: ref3/cit3 publication-title: J. Clin. Invest. doi: 10.1172/JCI118699 – volume: 77 start-page: 491 year: 1994 ident: ref39/cit39 publication-title: Cell doi: 10.1016/0092-8674(94)90212-7 – volume: 47 start-page: 520 year: 2006 ident: ref49/cit49 publication-title: J. Nucl. Med. – volume: 5 start-page: 2473 year: 1995 ident: ref37/cit37 publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/0960-894X(95)00426-T – volume: 57 start-page: 176 year: 2005 ident: ref10/cit10 publication-title: Ann. Neurol. doi: 10.1002/ana.20369 – volume: 290 start-page: 854 year: 1999 ident: ref32/cit32 publication-title: J. Pharmacol. Exp. Ther. doi: 10.1016/S0022-3565(24)34974-2 – volume: 23 start-page: 121 year: 1988 ident: ref33/cit33 publication-title: J. Neurosci. Methods doi: 10.1016/0165-0270(88)90184-7 – volume: 4 start-page: S22 year: 2002 ident: ref46/cit46 publication-title: Mol. Imaging Biol. – volume: 76 start-page: 1121 year: 2001 ident: ref6/cit6 publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.2001.00113.x – volume: 38 start-page: 977 year: 1993 ident: ref22/cit22 publication-title: Dig. Dis. Sci. doi: 10.1007/BF01295711 – volume: 68 start-page: 231 year: 2000 ident: ref23/cit23 publication-title: Clin. Pharmacol. Ther. doi: 10.1067/mcp.2000.109156 – volume: 44 start-page: 1330 year: 2003 ident: ref17/cit17 publication-title: J. Nucl. Med. – volume: 32 start-page: 943 year: 2004 ident: ref25/cit25 publication-title: Drug Metab. Dispos. doi: 10.1016/S0090-9556(24)02977-5 – volume: 103 start-page: 121 year: 2003 ident: ref31/cit31 publication-title: Int. J. Cancer doi: 10.1002/ijc.10792 – volume: 63 start-page: 1038 year: 2004 ident: ref9/cit9 publication-title: J. Neuropath. Exp. Neurol. doi: 10.1093/jnen/63.10.1038 – volume: 115 start-page: 3285 year: 2005 ident: ref7/cit7 publication-title: J. Clin. Invest. doi: 10.1172/JCI25247 – volume: 25 start-page: 287 year: 1997 ident: ref1/cit1 publication-title: Adv. Drug Delivery Rev. doi: 10.1016/S0169-409X(97)00504-8 – volume: 10 start-page: 1493 year: 2004 ident: ref13/cit13 publication-title: Curr. Pharm. Des. doi: 10.2174/1381612043384736 – volume: 41 start-page: 493 year: 2000 ident: ref14/cit14 publication-title: J. Nucl. Med. – volume: 47 start-page: 1427 year: 2006 ident: ref16/cit16 publication-title: J. Nucl. Med. – volume: 44 start-page: 1330 year: 2003 ident: WOS:000184650900024 article-title: Biodistribution, radiation dose estimates, and in vivo Pgp modulation studies of F-18-paclitaxel in nonhuman primates publication-title: JOURNAL OF NUCLEAR MEDICINE – year: 2001 ident: WOS:000259760500021.28 publication-title: RAT BRAIN STEREOTAXI – volume: 46 start-page: 199 year: 1977 ident: WOS:A1977ED77900002 article-title: RECEPTOR AFFINITY AND PHARMACOLOGICAL POTENCY OF A SERIES OF NARCOTIC ANALGESIC, ANTI-DIARRHEAL AND NEUROLEPTIC DRUGS publication-title: EUROPEAN JOURNAL OF PHARMACOLOGY – volume: 6 start-page: 253 year: 1979 ident: WOS:A1979HL69800005 article-title: METABOLITES OF LOPERAMIDE IN RATS publication-title: BIOMEDICAL MASS SPECTROMETRY – volume: 41 start-page: 493 year: 2000 ident: WOS:000085725300023 article-title: Evaluation of C-11-colchicine for PET imaging of multiple drug resistance publication-title: JOURNAL OF NUCLEAR MEDICINE – volume: 47 start-page: 520 year: 2006 ident: WOS:000249695800023 article-title: PET imaging of the dopamine transporter with F-18-FECNT: A polar radiometabolite confounds brain radioligand measurements publication-title: JOURNAL OF NUCLEAR MEDICINE – volume: 24 start-page: 150 year: 1997 ident: WOS:A1997WL94900008 article-title: In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients publication-title: EUROPEAN JOURNAL OF NUCLEAR MEDICINE – volume: 48 start-page: 207 year: 2007 ident: WOS:000244115600025 article-title: Imaging delta- and mu-opioid receptors by PET in lung carcinoma patients publication-title: JOURNAL OF NUCLEAR MEDICINE – volume: 48 start-page: S142 year: 2005 ident: WOS:000267210100139 article-title: PRODUCTION OF THE P-GLYCOPROTEIN MARKER, [C-11]LOPERAMIDE, IN CLINICALLY USEFUL QUANTITIES publication-title: JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS – volume: 37 start-page: 1571 year: 1996 ident: WOS:A1996VF79700046 article-title: Carbon-11-labeled daunorubicin and verapamil for probing P-glycoprotein in tumors with PET publication-title: JOURNAL OF NUCLEAR MEDICINE – volume: 10 start-page: 1493 year: 2004 ident: WOS:000221066400004 article-title: PET studies on P-glycoprotein function in the blood-brain barrier: How it affects uptake and binding of drugs within the CNS publication-title: CURRENT PHARMACEUTICAL DESIGN – volume: 63 start-page: 1038 year: 2004 ident: WOS:000224500300004 article-title: Altered P-glycoprotein expression in AIDS patients with HIV encephalitis publication-title: JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY – volume: 101 start-page: 289 year: 1998 ident: WOS:000071668000002 article-title: The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors publication-title: JOURNAL OF CLINICAL INVESTIGATION – year: 1996 ident: WOS:000259760500021.6 publication-title: GUIDE CARE USE LAB A – volume: 5 start-page: 2473 year: 1995 ident: WOS:A1995TC82800005 article-title: METHANODIBENZOSUBERYLPIPERAZINES AS POTENT MULTIDRUG-RESISTANCE REVERSAL AGENTS publication-title: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS – volume: 48 start-page: 153 year: 1997 ident: WOS:A1997WF43900001 article-title: Synthesis of [C-11]iodomethane by iodination of [C-11]methane publication-title: APPLIED RADIATION AND ISOTOPES – volume: 32 start-page: 943 year: 2004 ident: WOS:000223375500010 article-title: Identification of an N-methyl-4-phenylpyridinium-like metabolite of the antidiarrheal agent loperamide in human liver microsomes: Underlying reason(s) for the lack of neurotoxicity despite the bioactivation event publication-title: DRUG METABOLISM AND DISPOSITION – volume: 44 start-page: 163P year: 2003 ident: WOS:000182729600530 article-title: A single slice rebinning/2D exact positioning OSEM reconstruction for the NIH ATLAS small animal PET scanner. publication-title: JOURNAL OF NUCLEAR MEDICINE – start-page: 136 year: 1997 ident: WOS:000259760500021.49 publication-title: J LABELLED COMP RADI – volume: 103 start-page: 121 year: 2003 ident: WOS:000179696100019 article-title: Modulation of P-glycoprotein but not MRPI- or BCRP-mediated drug resistance by LY335979 publication-title: INTERNATIONAL JOURNAL OF CANCER doi: 10.1002/ijc.10792 – volume: 46 start-page: 484 year: 2005 ident: WOS:000227481700023 article-title: C-11-GR103545, a radiotracer for imaging kappa-opioid receptors in vivo with PET: Synthesis and evaluation in baboons publication-title: JOURNAL OF NUCLEAR MEDICINE – volume: 38 start-page: 977 year: 1993 ident: WOS:A1993LG50500001 article-title: LOPERAMIDE - SURVEY OF STUDIES ON MECHANISM OF ITS ANTIDIARRHEAL ACTIVITY publication-title: DIGESTIVE DISEASES AND SCIENCES – volume: 57 start-page: 176 year: 2005 ident: WOS:000226633800004 article-title: Blood-brain barrier dysfunction in Parkinsonian midbrain in vivo publication-title: ANNALS OF NEUROLOGY doi: 10.1002/ana.20369 – start-page: 447 year: 1989 ident: WOS:000259760500021.44 publication-title: MIRD RADIONUCLIDE DA – volume: 290 start-page: 854 year: 1999 ident: WOS:000081583900051 article-title: Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities publication-title: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS – volume: 5 start-page: 121 year: 2003 ident: WOS:000259760500021.27 publication-title: MOL IMAGING BIOL – volume: 4 start-page: 30 ident: MEDLINE:15967124 article-title: Imaging multidrug resistance P-glycoprotein transport function using microPET with technetium-94m-sestamibi. publication-title: Molecular imaging – volume: 16 start-page: 782 year: 1973 ident: WOS:A1973Q001400009 article-title: SYNTHETIC ANTIDIARRHEAL AGENTS - 2,2-DIPHENYL-4-(4'-ARYL-4'-HYDROXYPIPERIDINO)BUTYRAMIDES publication-title: JOURNAL OF MEDICINAL CHEMISTRY – volume: 77 start-page: 491 year: 1994 ident: WOS:A1994NM83200005 article-title: DISRUPTION OF THE MOUSE MDR1A P-GLYCOPROTEIN GENE LEADS TO A DEFICIENCY IN THE BLOOD-BRAIN-BARRIER AND TO INCREASED SENSITIVITY TO DRUGS publication-title: CELL – volume: 50 start-page: 1347 year: 2003 ident: WOS:000185922200005 article-title: Resolution uniformity and sensitivity of the NIH ATLAS small animal PET scanner: Comparison to simulated LSO scanners without depth-of-interaction capability publication-title: IEEE TRANSACTIONS ON NUCLEAR SCIENCE doi: 10.1109/TNS.2003.817282 – volume: 115 start-page: 3285 year: 2005 ident: WOS:000233022100038 article-title: P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model publication-title: JOURNAL OF CLINICAL INVESTIGATION doi: 10.1172/JCI25247 – volume: 2 start-page: 48 year: 2002 ident: WOS:000180397700014 article-title: Multidrug resistance in cancer: Role of ATP-dependent transporters publication-title: NATURE REVIEWS CANCER doi: 10.1038/nrc706 – volume: 4 start-page: S22 year: 2002 ident: WOS:000259760500021.14 publication-title: MOL IMAGING BIOL – volume: 7 start-page: 37 year: 2005 ident: WOS:000244957700007 article-title: Positron emission tomography studies on binding of central nervous system drugs and P-glycoprotein function in the rodent brain publication-title: MOLECULAR IMAGING AND BIOLOGY doi: 10.1007/s11307-005-0951-x – volume: 12 start-page: 535 year: 2002 ident: WOS:000178635900005 article-title: Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans publication-title: PHARMACOGENETICS – volume: 68 start-page: 231 year: 2000 ident: WOS:000089560000002 article-title: Increased drug delivery to the brain by P-glycoprotein inhibition publication-title: CLINICAL PHARMACOLOGY & THERAPEUTICS doi: 10.1067/mcp.2000.109156 – volume: 76 start-page: 1121 year: 2001 ident: WOS:000167049800019 article-title: beta-Amyloid efflux mediated by p-glycoprotein publication-title: JOURNAL OF NEUROCHEMISTRY – volume: 49 start-page: 649 year: 2008 ident: WOS:000254813600026 article-title: C-11-loperamide and its N-desmethyl radiometabolite are avid substrates for brain permeability-glycoprotein efflux publication-title: JOURNAL OF NUCLEAR MEDICINE doi: 10.2967/jnumed.107.047308 – volume: 18 start-page: 281 year: 1991 ident: WOS:A1991FF20500003 article-title: A COMPARISON OF THE BRAIN UPTAKE OF N-(CYCLOPROPYL[C-11]METHYL) NORBUPRENORPHINE ([C-11]BUPRENORPHINE) AND N-(CYCLOPROPYL[C-11]METHYL NORDIPRENORPHINE ([C-11]DIPRENORPHINE) IN BABOON USING PET publication-title: NUCLEAR MEDICINE AND BIOLOGY – volume: 23 start-page: 121 year: 1988 ident: WOS:A1988M531900006 article-title: REGIONAL CEREBRAL OPIOID RECEPTOR STUDIES WITH [C-11] DIPRENORPHINE IN NORMAL VOLUNTEERS publication-title: JOURNAL OF NEUROSCIENCE METHODS – year: 2003 ident: WOS:000259760500021.4 publication-title: IEEE NUCL SCI S MED – volume: 51 start-page: 17 year: 2008 ident: WOS:000252127200003 article-title: Synthesis and evaluation in monkey of two sensitive C-11-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm0707370 – volume: 25 start-page: 287 year: 1997 ident: WOS:A1997XJ12900008 article-title: Blood-brain barrier function of P-glycoprotein publication-title: ADVANCED DRUG DELIVERY REVIEWS – volume: 61 start-page: 96 year: 2007 ident: WOS:000242789700005 article-title: Effect of a P-glycoprotein inhibitor, cyclosporin A, on the disposition in rodent brain and blood of the 5-HT1A receptor radioligand, [C-11](R)-(-)-RWAY publication-title: SYNAPSE doi: 10.1002/syn.20348 – volume: 97 start-page: 2517 year: 1996 ident: WOS:A1996UQ23800016 article-title: P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs publication-title: JOURNAL OF CLINICAL INVESTIGATION – volume: 7 start-page: 139 year: 1993 ident: BCI:BCI199345056897 article-title: Positron-emitting radioligands for studies in vivo: Probes for human psychopharmacology publication-title: Journal of Psychopharmacology – volume: 47 start-page: 1427 year: 2006 ident: WOS:000240460600010 article-title: Evaluation of in vivo P-glycoprotein function at the blood-brain barrier among MDR1 gene polymorphisms by using C-11-verapamil publication-title: JOURNAL OF NUCLEAR MEDICINE – volume: 38 start-page: 1277 year: 1990 ident: WOS:A1990DV50300004 article-title: EXPRESSION OF THE MULTIDRUG RESISTANCE GENE-PRODUCT (P-GLYCOPROTEIN) IN HUMAN NORMAL AND TUMOR-TISSUES publication-title: JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY – volume: 5 start-page: 376 ident: MEDLINE:14667492 article-title: Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents. publication-title: Molecular imaging and biology |
SSID | ssj0003123 |
Score | 2.2305312 |
Snippet | [11C]Loperamide has been proposed for imaging P-glycoprotein (P-gp) function with positron emission tomography (PET), but its metabolism to... [C-11]Loperamide has been proposed for imaging P-glycoprotein (P-gp) function with positron emission tomography (PET), but its metabolism to... [(11)C]Loperamide has been proposed for imaging P-glycoprotein (P-gp) function with positron emission tomography (PET), but its metabolism to [N-methyl-(11)C]... [ 11 C]Loperamide has been proposed for imaging P-glycoprotein (P-gp) function with positron emission tomography (PET), but its metabolism to [ N-methyl - 11... |
Source | Web of Science |
SourceID | pubmedcentral pubmed pascalfrancis webofscience crossref istex acs |
SourceType | Open Access Repository Index Database Enrichment Source Publisher |
StartPage | 6034 |
SubjectTerms | Animals ATP Binding Cassette Transporter, Subfamily B - deficiency ATP Binding Cassette Transporter, Subfamily B - metabolism Biological and medical sciences Brain - diagnostic imaging Brain - metabolism Carbon Radioisotopes Chemistry, Medicinal Contrast media. Radiopharmaceuticals Injections, Intravenous Life Sciences & Biomedicine Loperamide - analogs & derivatives Loperamide - chemical synthesis Loperamide - chemistry Loperamide - pharmacokinetics Macaca mulatta Male Medical sciences Mice Mice, Knockout Molecular Structure Pharmacology & Pharmacy Pharmacology. Drug treatments Positron-Emission Tomography - methods Radiopharmaceuticals - chemical synthesis Radiopharmaceuticals - chemistry Radiopharmaceuticals - pharmacokinetics Science & Technology Stereoisomerism Time Factors |
Title | Synthesis and Evaluation of [N-methyl-11C]N-Desmethyl-loperamide as a New and Improved PET Radiotracer for Imaging P-gp Function |
URI | http://dx.doi.org/10.1021/jm800510m https://api.istex.fr/ark:/67375/TPS-L2WP4Z7V-1/fulltext.pdf http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000259760500021 https://www.ncbi.nlm.nih.gov/pubmed/18783208 https://pubmed.ncbi.nlm.nih.gov/PMC2646255 |
Volume | 51 |
WOS | 000259760500021 |
WOSCitedRecordID | wos000259760500021 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Jb9NAFB6V9gAXlrKZpRpBFXGoi2e8H5FJVCGoLJJCBULWeBYITZwodiXCiZ_Om_GSBMJys-X3vDx_8xZ75nsIHUpIqUOipO2pOLQ94UR2FISuHWgm6DwKODfLx96cBidn3qtz_3wHPf3DH3xKnn-dRgY50ytojwYweHX-kww7d-sS6raU4BSCeUsftK6qQw8vN0LPnrbiNz0VkpVgDVW3sViLQ9vmSP4Sl0wMGtxAL9uVPPXUk4vjyyo_5t9_J3b82-PdRNebHBS_qEFzC-3IYh9dTdrWb_uol9aE1ssjPFqtzyqPcA-nK6rr5W30Y7gsIIMsxyVmhcD9jjoczxT-CE5aAg4mNiHJp1MbStxmfzKbw1mnYyExA00Mntbo1184pMBpf4TfMjGegVG4XGDIrOGgaaiEU_vzHA8gHOvr3EFng_4oObGbng42852gspUTSk4VyznhIRUkJ36kAM2-67s5g_QO0BJEMo4iAWDhQjtkwnhAmOvwmOTuXbRbzAp5H2Go5CB5VT5TinlQl-aBckWu9BmEVHlsoQN46VkzJsvM_G6nUO60FrfQsxYPGW8Y0XVjjsk20Sed6LymAdkm1DOg6iTY4kLPmwv9bJQOs9f0fep9CN9lBO5sA3WdAjXdX3xqoXs1-lYXi0LwvU5koXADl52ApgnfPFKMvxi6cEh5ocj1LXS4juBOUcdEGK9Q1uotuDfyP2JJYy_NnFA9-JelH6JrtOURjh-h3WpxKR9DMlflB2Yw_wT1REQS |
linkProvider | American Chemical Society |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLZgexgvXMYtXDYLTRUPy4hzz-MUteqgqyKawcSEIsexoaxNqyaTKE_8dI6dS9upEntrlXMc5-jzuST2dxA64pBSe0Rw3RaBp9uZ4eu-61m6K5mgU99lTB0fOx-6_Qv746VzWdPkyLMwMIkCRirUR_wVuwD58GvqKwBN76NdSEJMiebTcNR6XYuYVsMMbkJMb1iE1lVlBGLFRgTalcb8LXdE0gKMIqpuFmvhaNtWyVvhSYWi3qOqp5F6CLUD5frkpkxP2J9b_I53e8rH6GGdkeLTCkJP0D2e76O9sGkEt486UUVvvTzG8eq0VnGMOzhaEV8vn6K_o2UO-WQxLjDNM9xticTxTOArcNkcUDHRCQm_D3UoeOv_k9kcRp2OM44paGLwu0q_et_BMxx1Y_yZZuMZ2IbxBYY8Gy6q9ko40n_McQ-Cs7zPM3TR68ZhX687POjUMdxSF4bHmSloygjzzIykxPEFYNuxHCulkOwBdlyfB76fAXRYJt0zocwl1DJYQFLrOdrJZzl_iTDUdZDKCocKQW2oUlNXWFkq5AgZF2mgoQMweFKv0CJRH99NKH4ai2vofQOLhNX86LJNx2Sb6LtWdF6RgmwT6ihstRJ0cS130XlOEkejZGB-jexv3peEwMw2wNcqmKoXjGNq6EUFwtXNfA88seFryNuAZysgScM3r-Tjn4o8HBJgKHkdDR2tA7lVlBESVi8UufIXzI3cRSys7SV5FMpX_7P0Idrrx-eDZHA2_PQaPTAbhuHgDdopFzf8LaR5ZXqg1vc_cbNMcw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLZgk2AvXAaMcBkWmioelhHnnscptBowSkQ7mEAocnyBsjatmkyiPPHTOXYubadK7C1RznGco88-58T2dxA6EBBSB0QK05VRYLrcCs3QDxzTV0zQWegzpo-Pfej7J2fuu3PvvE4U1VkY6EQBLRV6EV-N6hmXNcMAef1rEmoQTW6ibbVcpxB9HA_amdchttOwg9vg1xsmoVVV5YVYseaFtpVBf6tdkbQAw8iqosWKS9q0XfKKi9LuqHcXfWw_RO9CuTi6LLMj9ucKx-P1v_QeulNHpvi4gtJ9dEPku-h23BSE20WdpKK5Xhzi4fLUVnGIOzhZEmAvHqC_g0UOcWUxKjDNOe62hOJ4KvE3mLoFoGNsEhJ_75uQ-Nb34-kMWp2MuMAUNDHMv1q_-u8hOE66Q_yJ8tEU7MPEHEO8DQ91mSWcmD9muAdOWr3nITrrdYfxiVlXejCpZ_mlKa1AMFvSjBEW2JxkxAslYNxzPCejEPQBhvxQRGHIAUKMq2maUOYT6lgsIpnzCG3l01w8RhjyOwhppUelpC5kq5kvHZ5J1QIXMosMtA9GT-uRWqR6Ed6GJKixuIFeNdBIWc2Trsp1jDeJvmxFZxU5yCahjsZXK0HnF2o3XeClw2SQntpfEvdr8Dkl0LM1ALYKtq4J49kG2quAuHxZGMCMbIUGCtYg2goo8vD1J_nopyYRh0AYUl_PQAerYG4VlaeEUQzJrrqCvpHriMW1vRSfQvnkf5Z-gW4lb3rp6dv--6dox26IhqNnaKucX4rnEO2V2b4e4v8AAw9O9g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesis+and+Evaluation+of+%5B+N-+methyl-+11+C%5D+N+-Desmethyl-loperamide+as+a+New+and+Improved+PET+Radiotracer+for+Imaging+P-gp+Function&rft.jtitle=Journal+of+medicinal+chemistry&rft.au=Lazarova%2C+Neva&rft.au=Zoghbi%2C+Sami+S.&rft.au=Hong%2C+Jinsoo&rft.au=Seneca%2C+Nicholas&rft.date=2008-10-09&rft.issn=0022-2623&rft.eissn=1520-4804&rft.volume=51&rft.issue=19&rft.spage=6034&rft.epage=6043&rft_id=info:doi/10.1021%2Fjm800510m&rft.externalDBID=n%2Fa&rft.externalDocID=10_1021_jm800510m |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2623&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2623&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2623&client=summon |